Center for State, Tribal, Local, and Territorial Support (CSTLTS), CDC/ATSDR Tribal Consultation Session, 35298-35299 [2021-14205]
Download as PDF
<![CDATA[
35298
Federal Register / Vol. 86, No. 125 / Friday, July 2, 2021 / Notices
partners across state health departments
and collaborating divisions within CDC.
The information collection and
reporting requirements have been
carefully designed to align with, and
support the specific goals and outcomes
outlined in the Core SIPP cooperative
agreement. The overarching goal of Core
SIPP is to strengthen the awardee’s
injury prevention programs and policies
and demonstrate impact in the
reduction of injury-related morbidity
and mortality. Although the data are
limited to the 23 recipients of the Core
SIPP NOFO, the results can be
generalizable and inform injury
prevention work. Moreover, it is
asserted that the results of the data
collection are vital to ensuring the Core
SIPPs efficient management. Results
will not only allow NCIPC staff to
provide data-driven technical assistance
to recipients, but also to assess patterns
across other NCIPC injury prevention
programs such as, Prescription Drug
Overdose Prevention for States and the
Injury Control Research Centers. In
addition, the data collection will inform
the continuous quality improvement
process and allow NCIPC staff to make
mid-course corrections and describe the
impact on health outcomes.
prevention and control strategies
implemented by recipients through the
development of journal articles, tools,
templates, and other injury prevention
resources/products.
Program recipients will use the
information collected to manage and
coordinate their activities and to
improve their efforts to prevent and
control injuries. The Partners’ Portal
allows recipients to fulfill their annual
reporting obligations efficiently by
employing user-friendly, easily
accessible web-based instruments to
collect necessary information for both
progress reports and continuation
applications including work plans. This
approach enables recipients to save
pertinent information from one
reporting period to the next and reduces
the administrative burden on the annual
continuation application and the
performance monitoring process.
Awardee program staff are able to
review the completeness of data needed
to generate required reports, enter basic
summary data for reports annually, and
finalize and save required reports for
upload into other reporting systems as
required.
The information collection
procedures will also allow NCIPC to
respond to inquiries from the HHS, the
White House, Congress and other
stakeholders about program activities
and their impact; as well as, work
towards CDCs overarching mission to
protect America from health, safety and
security threats, both foreign and in the
U.S. NCIPC will use the information
collected in the Partners’ Portal to
perform program activities to
accomplish the following objectives:
• Monitor each awardee’s progress
and identify facilitators and barriers to
program implementation and
achievement of outcomes. Monitoring
allows NCIPC to determine whether an
awardee is meeting performance goals,
to inform awardee continuous quality
improvements, and to inform the type of
intensity of CDC-provided technical
assistance to support attainment of their
performance measures.
• Identify trends in injury
surveillance data to inform state foci for
prevention and intervention strategies
as well as the production of relevant
reports, journal articles, and resources
for state health departments.
• Identify, translate, and disseminate
information about successful injury
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
(in hours)
Form name
Core SIPP Program Recipients ........
Annual Progress Report ...................
23
1
11
253
Total ...........................................
...........................................................
........................
........................
........................
253
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
(ATSDR), Department of Health and
Human Services (HHS).
ACTION: Notice of meeting.
[FR Doc. 2021–14224 Filed 7–1–21; 8:45 am]
SUMMARY:
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Agency for Toxic Substances and
Disease Registry
lotter on DSK11XQN23PROD with NOTICES1
Number of
respondents
Type of respondents
Center for State, Tribal, Local, and
Territorial Support (CSTLTS), CDC/
ATSDR Tribal Consultation Session
Centers for Disease Control and
Prevention (CDC)/Agency for Toxic
Substances and Disease Registry
AGENCY:
VerDate Sep<11>2014
18:50 Jul 01, 2021
Jkt 253001
The Centers for Disease
Control and Prevention (CDC)/Agency
for Toxic Substances and Disease
Registry (ATSDR), announces the 2021
CDC/ATSDR Tribal Consultation
Session. CDC/ATSDR will host
American Indian and Alaska Native (AI/
AN) Federally Recognized Tribes for the
virtual tribal consultation session. The
proceedings will be open to the public.
DATES: The tribal consultation will be
held on August 5, 2021, from 3:15 p.m.
to 5:00 p.m., EDT. Written tribal
testimony is due by 5:00 p.m., EDT, on
September 7, 2021.
ADDRESSES: Zoom Virtual Tribal
Consultation. To register, see CDC web
page https://cdc.zoomgov.com/meeting/
register/vJIsfu-gqDgsGD1rTre7HPjbXy
IF3v5jSp4. All elected tribal officials are
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
encouraged to submit written tribal
testimony to the contact person and
mailing address listed below or by email
at Tribalsupport@cdc.gov.
FOR FURTHER INFORMATION CONTACT:
Captain Karen Hearod, MSW, LCSW,
Director, Office of Tribal Affairs and
Strategic Alliances, Center for State,
Tribal, Local, and Territorial Support,
CDC, 1600 Clifton Road NE, Mailstop
V18–4, Atlanta, GA 30329–4027;
Telephone: (404) 498–0300; Email:
Tribalsupport@cdc.gov.
SUPPLEMENTARY INFORMATION: This
meeting is being held in accordance
with Presidential Executive Order No.
13175, November 6, 2000, and the
Presidential Memorandum of November
5, 2009, and September 23, 2004,
Consultation and Coordination with
Indian Tribal Governments.
Purpose: The purpose of the
consultation meeting is to advance CDC/
ATSDR support for and collaboration
E:\FR\FM\02JYN1.SGM
02JYN1
lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 86, No. 125 / Friday, July 2, 2021 / Notices
with AI/AN tribal nations and to
improve the health of AI/AN tribal
nations by pursuing goals that include
assisting in eliminating the health
disparities faced by AI/AN tribal
nations; ensuring that access to critical
health and human services and public
health services is maximized to advance
or enhance the social, physical, and
economic status of AI/AN people; and
promoting health equity for all Indian
people and communities. To advance
these goals, CDC/ATSDR conducts
government-to-government
consultations with elected tribal
officials or their authorized
representatives. Consultation is an
enhanced form of communication that
emphasizes trust, respect, and shared
responsibility. It is an open and free
exchange of information and opinion
among parties that leads to mutual
understanding.
Matters To Be Considered: CDC/
ATSDR is hosting this meeting to hold
a consultation with federally recognized
tribal nations to receive input and
guidance on improving the current
CDC/ATSDR Tribal Consultation Policy.
CDC/ATSDR is seeking feedback on
how the agency can improve its policies
and practices to better engage with
Indian Country through meaningful
consultation. This feedback will be used
to edit the current CDC’s Consultation
Policy. The Tribal consultation session
will provide opportunities for elected
AI/AN tribal officials to speak openly
about the public health issues affecting
their tribal nations. This consultation
session is virtual and open to the public.
Elected tribal officials can find guidance
to assist in developing tribal testimony
for CDC/ATSDR at https://www.cdc.gov/
tribal/documents/consultation/TribalTestimony-Guidance.pdf. Please submit
tribal testimony on official tribal
letterhead.
Based on the number of elected tribal
officials giving testimony and the time
available, it may be necessary to limit
the time for each presenter. We will
adjourn tribal consultation meetings
early if all attendees who requested to
provide oral testimony in advance of
and during the consultation have
delivered their comments. Agenda items
are subject to change as priorities
dictate.
Additional information about CDC/
ATSDR’s Tribal Consultation Policy can
be found at https://www.cdc.gov/tribal/
consultation-support/tribalconsultation/policy.html.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
VerDate Sep<11>2014
17:12 Jul 01, 2021
Jkt 253001
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2021–14205 Filed 7–1–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2021–0034]
Advisory Committee on Immunization
Practices (ACIP); Amended Notice of
Meeting
Notice is hereby given of a change in
the meeting of the Advisory Committee
on Immunization Practices (ACIP); June
23, 2021, from 10:00 a.m. to 5:00 p.m.,
EDT (times subject to change); June 24,
2021, from 10:30 a.m. to 5:10 p.m., EDT
(times subject to change); and June 25,
2021, from 10:00 a.m. to 12:20 p.m.,
EDT (times subject to change), in the
amended FRN. The virtual meeting was
published in the Federal Register on
Wednesday, June 23, 2021, Volume 86,
Number 118, pages 32933–32934.
The virtual meeting is being amended
to update the meeting times on June 23–
25, 2021 (times subject to change) and
matters to be considered and should
read as follows:
SUMMARY: In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC), announces the
following meeting of the Advisory
Committee on Immunization Practices
(ACIP). This meeting is open to the
public. Time will be available for public
comment. The meeting will be webcast
live via the World Wide Web; for more
information on ACIP please visit the
ACIP website: https://www.cdc.gov/
vaccines/acip/.
DATES: The meeting will be held on June
23, 2021, from 11:00 a.m. to 4:00 p.m.,
EDT (times subject to change); June 24,
2021, from 10:00 a.m. to 5:15 p.m., EDT
(times subject to change); and June 25,
2021, from 10:00 a.m. to 1:00 p.m., EDT
(times subject to change). Written
comments must be received on or before
June 25, 2021.
A notice of this ACIP meeting has also
been posted on CDC’s ACIP website at:
https://www.cdc.gov/vaccines/acip/
PO 00000
Frm 00041
Fmt 4703
Sfmt 9990
35299
index.html. In addition, CDC has sent
notice of this ACIP meeting by email to
those who subscribe to receive email
updates about ACIP.
FOR FURTHER INFORMATION CONTACT:
Stephanie Thomas, ACIP Committee
Management Specialist, Centers for
Disease Control and Prevention,
National Center for Immunization and
Respiratory Diseases, 1600 Clifton Road
NE, MS–H24–8, Atlanta, GA 30329–
4027; Telephone: 404–639–8367; Email:
ACIP@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The committee is charged
with advising the Director, CDC, on the
use of immunizing agents. In addition,
under 42 U.S.C. 1396s, the committee is
mandated to establish and periodically
review and, as appropriate, revise the
list of vaccines for administration to
vaccine-eligible children through the
Vaccines for Children (VFC) program,
along with schedules regarding dosing
interval, dosage, and contraindications
to administration of vaccines. Further,
under provisions of the Affordable Care
Act, section 2713 of the Public Health
Service Act, immunization
recommendations of the ACIP that have
been approved by the Director of the
Centers for Disease Control and
Prevention and appear on CDC
immunization schedules must be
covered by applicable health plans.
Matters To Be Considered: The agenda
will include discussions on COVID–19,
dengue vaccine, herpes zoster vaccines,
influenza vaccines, pneumococcal
vaccine, and rabies vaccine.
Recommendation votes on dengue
vaccine, influenza vaccines and rabies
vaccine are scheduled. Vaccines for
Children (VFC) votes on dengue vaccine
and influenza vaccines are scheduled.
Agenda items are subject to change as
priorities dictate. For more information
on the meeting agenda visit https://
www.cdc.gov/vaccines/acip/meetings/
meetings-info.html.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2021–14203 Filed 7–1–21; 8:45 am]
BILLING CODE 4163–18–P
E:\FR\FM\02JYN1.SGM
02JYN1
]]>Agencies
[Federal Register Volume 86, Number 125 (Friday, July 2, 2021)]
[Notices]
[Pages 35298-35299]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-14205]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Agency for Toxic Substances and Disease Registry
Center for State, Tribal, Local, and Territorial Support
(CSTLTS), CDC/ATSDR Tribal Consultation Session
AGENCY: Centers for Disease Control and Prevention (CDC)/Agency for
Toxic Substances and Disease Registry (ATSDR), Department of Health and
Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC)/Agency
for Toxic Substances and Disease Registry (ATSDR), announces the 2021
CDC/ATSDR Tribal Consultation Session. CDC/ATSDR will host American
Indian and Alaska Native (AI/AN) Federally Recognized Tribes for the
virtual tribal consultation session. The proceedings will be open to
the public.
DATES: The tribal consultation will be held on August 5, 2021, from
3:15 p.m. to 5:00 p.m., EDT. Written tribal testimony is due by 5:00
p.m., EDT, on September 7, 2021.
ADDRESSES: Zoom Virtual Tribal Consultation. To register, see CDC web
page https://cdc.zoomgov.com/meeting/register/vJIsfu-gqDgsGD1rTre7HPjbXyIF3v5jSp4. All elected tribal officials are
encouraged to submit written tribal testimony to the contact person and
mailing address listed below or by email at [email protected].
FOR FURTHER INFORMATION CONTACT: Captain Karen Hearod, MSW, LCSW,
Director, Office of Tribal Affairs and Strategic Alliances, Center for
State, Tribal, Local, and Territorial Support, CDC, 1600 Clifton Road
NE, Mailstop V18-4, Atlanta, GA 30329-4027; Telephone: (404) 498-0300;
Email: [email protected].
SUPPLEMENTARY INFORMATION: This meeting is being held in accordance
with Presidential Executive Order No. 13175, November 6, 2000, and the
Presidential Memorandum of November 5, 2009, and September 23, 2004,
Consultation and Coordination with Indian Tribal Governments.
Purpose: The purpose of the consultation meeting is to advance CDC/
ATSDR support for and collaboration
[[Page 35299]]
with AI/AN tribal nations and to improve the health of AI/AN tribal
nations by pursuing goals that include assisting in eliminating the
health disparities faced by AI/AN tribal nations; ensuring that access
to critical health and human services and public health services is
maximized to advance or enhance the social, physical, and economic
status of AI/AN people; and promoting health equity for all Indian
people and communities. To advance these goals, CDC/ATSDR conducts
government-to-government consultations with elected tribal officials or
their authorized representatives. Consultation is an enhanced form of
communication that emphasizes trust, respect, and shared
responsibility. It is an open and free exchange of information and
opinion among parties that leads to mutual understanding.
Matters To Be Considered: CDC/ATSDR is hosting this meeting to hold
a consultation with federally recognized tribal nations to receive
input and guidance on improving the current CDC/ATSDR Tribal
Consultation Policy. CDC/ATSDR is seeking feedback on how the agency
can improve its policies and practices to better engage with Indian
Country through meaningful consultation. This feedback will be used to
edit the current CDC's Consultation Policy. The Tribal consultation
session will provide opportunities for elected AI/AN tribal officials
to speak openly about the public health issues affecting their tribal
nations. This consultation session is virtual and open to the public.
Elected tribal officials can find guidance to assist in developing
tribal testimony for CDC/ATSDR at https://www.cdc.gov/tribal/documents/consultation/Tribal-Testimony-Guidance.pdf. Please submit tribal
testimony on official tribal letterhead.
Based on the number of elected tribal officials giving testimony
and the time available, it may be necessary to limit the time for each
presenter. We will adjourn tribal consultation meetings early if all
attendees who requested to provide oral testimony in advance of and
during the consultation have delivered their comments. Agenda items are
subject to change as priorities dictate.
Additional information about CDC/ATSDR's Tribal Consultation Policy
can be found at https://www.cdc.gov/tribal/consultation-support/tribal-consultation/policy.html.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-14205 Filed 7-1-21; 8:45 am]
BILLING CODE 4163-18-P
